2020 American Transplant Congress
The Noninvasive Urinary Sediment Double Immunostaining Test Predicts BK Polyomavirus Nephropathy in Kidney Transplant Recipients
*Purpose: This study aimed to improve the diagnostic value of decoy cells for BK polyomavirus associated-nephropathy (BKPyVAN) in kidney transplant recipients.*Methods: A total of 105…2020 American Transplant Congress
A New Diagnostic Approach to HLA Testing in Kidney Transplant Patients Using Renal Epithelial Cells
*Purpose: In this study we present a new diagnostic approach to HLA typing in kidney transplant recipients using cultured renal tubular cells from urine samples…2020 American Transplant Congress
Comparative Outcome Evaluation of Kidney Donors with and without Sickle Cell Trait
Multi-Organ Transplant Center, King Fahad Specialist Hospital, Dammam, Saudi Arabia
*Purpose: Kidney transplant programs in Saudi Arabia (KSA) are predominantly based on living kidney donation. Sickle cell trait (SCT) is prevalent in the Eastern and…2020 American Transplant Congress
Does Antibiotic Prophylaxis at Ureteral Stent Removal Reduce Urinary Tract Infections in Kidney Transplant Recipients?
*Purpose: Ureteral stents are commonly placed during kidney transplantation (KT). Urinary tract infections (UTI) are a common risk factor after KT and can have detrimental…2020 American Transplant Congress
Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria
*Purpose: BK polyomavirus nephropathy (BKVN) are important cause of dysfunction and failure of renal transplants, which is similar to T cell mediated rejection (TCMR) in…2020 American Transplant Congress
Rates of Urinary Tract Infections in Kidney Transplant Patients Using Trimethoprim/Sulfamethoxazole versus Alternative Agents for Pneumocystis Jiroveci Prophylaxis
Hennepin Healthcare, Minneapolis, MN
*Purpose: Trimethoprim/sulfamethoxazole (TMP/SMX) is used in kidney transplant patients for prophylaxis against Pneumocystis jiroveci pneumonia (PJP) and has demonstrated a decrease in the incidence of…2019 American Transplant Congress
The Impact of Antibiotic Therapy on Clinical Outcomes in Kidney Transplant Recipients with Asymptomatic Bacteriuria
1Michigan Medicine, Ann Arbor, MI, 2MedStar Georgetown University Hospital, Washington, DC
*Purpose: Asymptomatic bacteriuria (ASB) occurs in nearly 50% of kidney transplant recipients (KTRs) in the first year post-transplant. Data evaluating the risk of untreated ASB…2019 American Transplant Congress
Elevated Urinary Injury Biomarkers in Deceased Donors Are Not Associated with Long-Term Kidney Transplant Outcomes
*Purpose: In the United States, over 90,000 people are on the kidney transplant waiting list and could benefit from more donor organs. Kidneys from deceased-donors…2019 American Transplant Congress
Need of a New Formula to Estimate Creatinine Clearance in Immediate Post Kidney Transplant Period with Functioning Allograft
*Purpose: Introduction: Post kidney transplant (KTx), with functioning renal allograft, serum creatinine continues to decrease at a variable rate until it stabilizes after a few…2019 American Transplant Congress
Multidisciplinary Transplant UTI Service; Challenging the Stalemate
Guy's Hospital, London, United Kingdom
*Purpose: Symptomatic UTIs (urinary tract infections) cause a significantly detrimental effect on long term graft function. Immunosuppression coupled with underlying renal or urological abnormality makes…
American Transplant Congress abstracts